Product
LAIV
1 clinical trial
1 indication
Indication
Chronic Obstructive Pulmonary DiseaseClinical trial
Nasal Mucosal Immune Responses to Live Attenuated Influenza Virus (LAIV) in Chronic Obstructive Pulmonary Disease (COPD) Exacerbation PhenotypesStatus: Recruiting, Estimated PCD: 2025-03-01